SCHEMBL25543237

SCHEMBL25543237

N#Cc1ccc(-c2ccc(N(c3ccc(C#N)cc3)c3ccc(-c4nc5ccccc5o4)cc3)cn2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.44
ALDH1A1 P00352 4/20 0.44
HSD17B10 Q99714 4/20 0.44
TP53 P04637 3/20 0.44
HPGD P15428 3/20 0.44
KDM4E B2RXH2 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
RAB9A P51151 4/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
ATM Q13315 1/20 0.44
HDAC6 Q9UBN7 2/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA7 P36544 1/20 0.41
CHRNA10 Q9GZZ6 1/20 0.41
CHRNA9 Q9UGM1 1/20 0.41
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25544764 1.00 NPC1 (0.44) NPC1ALDH1A1HSD17B10TP53HPGD
SCHEMBL25544167 0.99 NPC1 (0.43) NPC1ALDH1A1HSD17B10TP53HPGD
SCHEMBL25543104 0.98 HSD17B10 (0.43) NPC1ALDH1A1HSD17B10TP53HPGD
SCHEMBL25543625 0.97 HSD17B10 (0.42) NPC1ALDH1A1HSD17B10TP53HPGD
SCHEMBL25543322 0.95 NPC1 (0.43) NPC1ALDH1A1HSD17B10TP53HPGD
SCHEMBL25543824 0.94 MET (0.42) NPC1ALDH1A1HSD17B10TP53HPGD
SCHEMBL25544372 0.94 NPC1 (0.42) NPC1ALDH1A1HSD17B10TP53HPGD
SCHEMBL25543488 0.92 NPC1 (0.38) NPC1ALDH1A1HSD17B10TP53HPGD
SCHEMBL25544621 0.91 ALDH1A1 (0.38) NPC1ALDH1A1HSD17B10TP53HPGD
SCHEMBL25543236 0.89 NPC1 (0.54) NPC1ALDH1A1HSD17B10TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 US disclosed
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME LAPTO CO., LTD. (KR) 2023-09-21 US disclosed
EP-4183784-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME Lapto Co., Ltd. (KR) 2023-05-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230301181-A1 TERTIARY AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME SAT1, FTO, SETDB1 NPC1 2875/4885ALDH1A1 16/4885HSD17B10 3107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.